Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  UnitedHealth Group    UNH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales130 474157 107184 828200 503218 085235 196
EBITDA11 75212 71415 33516 99820 12022 050
Operating profit (EBIT)10 27411 67214 16214 93117 63519 662
Pre-Tax Profit (EBT)------
Net income5 6195 8137 2379 11510 06511 258
P/E ratio17,719,621,420,518,516,2
EPS ( $ )5,706,017,489,3110,311,7
Dividend per Share ( $ )1,411,882,382,472,593,04
Yield1,39%1,60%1,48%1,30%1,36%1,59%
Reference price ( $ )101.09117.64160.04190.75190.75190.75
Announcement Date01/21/2015
11:00am
01/19/2016
10:55am
01/17/2017
10:55am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt8 17019 18319 69515 0057 2232 429
Finance------
Operating income (EBITDA)11 75212 71415 33516 99820 12022 050
Leverage
(Debt/EBITDA)
0,70x1,51x1,28x0,88x0,36x0,11x
Capital Expenditure1 4471 5561 7051 7991 9672 069
Book Value Per Share (BVPS)33,7 $35,4 $40,3 $47,7 $53,1 $59,8 $
Cash Flow per Share8,16 $10,1 $10,1 $12,5 $13,6 $15,0 $
Announcement Date01/21/2015
11:00am
01/19/2016
10:55am
01/17/2017
10:55am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 183 818 M$ -
Entreprise Value (EV) 198 823 M$ 191 041 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 20,5x 18,5x
Capitalization / Revenue 0,92x 0,84x
EV / Revenue 0,99x 0,88x
EV / EBITDA 11,7x 9,49x
Yield (DPS / Price) 1,30% 1,36%
Price to book (Price / BVPS) 4,00x 3,59x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 7,45% 8,09%
operating Leverage (Delta EBIT / Delta Sales) 0,64x 2,07x
Net Margin (Net Profit / Revenue) 4,55% 4,62%
ROA (Net Profit / Asset) 7,18% 7,45%
ROE (Net Profit / Equities) 21,6% 20,9%
Rate of Dividend 26,6% 25,0%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   0,90% 0,90%
Cash Flow / Sales 6,01% 6,01%
Capital Intensity (Assets / Sales) 0,63x 0,62x
Financial Leverage (Net Debt / EBITDA) 0,88x 0,36x
EPS & Dividend